Cancer Care Ontario | Action Cancer Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

5182 Results

Guidelines and Advice

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

Status: Current

Dec 1969

Guidelines and Advice

Mammographic Density and the Risk and Detection of Breast Cancer

Jan 2007

Guidelines and Advice

Integrating Care for Cancer Patients: An evidence-informed analysis

Jul 2014

Guidelines and Advice

ColonCancerCheck Recommendations for Post-Polypectomy Surveillance

Status: Current

Mar 2019

Document

CCOCancerPatientStagingGuidelines.pdf

Dec 1969

Guidelines and Advice

Best Practice Recommendations for Regimen Development and Maintenance

Status: Current
ID: GL-C50-25

Dec 1969

Programme de révision cas par cas (PRCC)

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Guidelines and Advice

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Status: Current
ID: GL-C50-27

Nov 2021

Guidelines and Advice

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

Status: Current
ID: GL-C50-09

Dec 1969

Guidelines and Advice

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Status: Current
ID: GL-C50-21

Jul 2015

Pages